Immunology
Last updated: 2021 Sep 7
Total hit(s): 7871
S.No.
1
34312570
A Unified Hierarchical XGBoost model for classifying priorities for COVID-19 vaccination campaign
Pattern Recognit
2022 Jan
7.35
1
2
33857058
Needless COVID-19 Vaccine Fears: A Psychological Perspective
Psychiatr Danub
2021 Spring
0.835 (5 year)
1
3
33898648
Seroprevalence of SARS-CoV-2 Antibody in Echocardiography and Stress Laboratory
J Patient Cent Res Rev
2021 Spring
1
4
33220855
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Lancet
2021 Dec 19
43.38
26
5
33220853
Age and frailty in COVID-19 vaccine development
Lancet
2021 Dec 19
43.38
1
6
34124322
Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies
Regen Ther
2021 Dec
1
7
34124327
An incentive-based approach may be the only approach to achieve COVID-19 herd immunity
Ethics Med Public Health
2021 Dec
0.27
1
8
33993845
Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates
Emerg Microbes Infect
2021 Dec
5.84
2
9
34057040
Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine
Emerg Microbes Infect
2021 Dec
5.84
1
10
34224330
Modulating the host immune response to fight against COVID-19: Where are we in 2021?
Virulence
2021 Dec
4.81
1
11
34308402
Case report of lymph node activation mimicking cancer progression: A false positive F(18) FDG PET CT after COVID-19 vaccination
Curr Probl Cancer Case Rep
2021 Dec
1
12
34278956
Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine
Emerg Microbes Infect
2021 Dec
5.84
1
13
34092181
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants
Emerg Microbes Infect
2021 Dec
5.84
1
14
33757410
Immune dysregulation and system pathology in COVID-19
Virulence
2021 Dec
4.81
1
15
34304724
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge
Emerg Microbes Infect
2021 Dec
5.84
1
16
34365904
Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice
Emerg Microbes Infect
2021 Dec
5.84
1
17
34306998
Factors associated with COVID-19 vaccine trust and hesitancy among adults with chronic conditions
Prev Med Rep
2021 Dec
3.8
1
18
33691606
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
Emerg Microbes Infect
2021 Dec
5.84
1
19
33830901
Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort
Emerg Microbes Infect
2021 Dec
5.84
1
20
34003073
Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients
Emerg Microbes Infect
2021 Dec
5.84
1
21
33890550
A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters
Emerg Microbes Infect
2021 Dec
5.84
1
22
34251989
The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences
Virulence
2021 Dec
4.81
1
23
34125647
Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA
Virulence
2021 Dec
4.81
1
24
34110974
Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution
Emerg Microbes Infect
2021 Dec
5.84
1
25
34002102
Global dynamics of SARS-CoV-2/cancer model with immune responses
Appl Math Comput
2021 Nov 1
1